Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Elicera Therapeutics AB

Closing information (x1000 NOK)

Closing information 2023/12 2022/12 2021/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 77 More Arrow 122 Less Arrow 0
Earnings before taxes -16,612 Less Arrow -18,388 More Arrow -2,753
EBITDA -17,307 Less Arrow -18,304 More Arrow -2,747
Total assets 30,573 More Arrow 43,803 More Arrow 53,382
Current assets 30,560 More Arrow 43,323 More Arrow 52,876
Current liabilities 13,959 Less Arrow 12,778 Less Arrow 2,438
Equity capital 16,615 More Arrow 31,025 More Arrow 50,944
- share capital 842 Less Arrow 786 More Arrow 810
Employees (average) 2 Equal arrow 2 Less Arrow 1

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 54.3% More Arrow 70.8% More Arrow 95.4%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -54.1% More Arrow -41.7% More Arrow -5.2%
Current ratio 218.9% More Arrow 339.0% More Arrow 2168.8%
Return on equity (ROE) -100.0% More Arrow -59.3% More Arrow -5.4%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 More Arrow 1 Less Arrow 0
Chg. No. of employees % 0% More Arrow 100% Less Arrow 0%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.